OMURKAN FINLEY: Open Payments
NPI 1538676838 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 7 payments from 6 companies in 2025. Trend: 2023 $422 · 2024 $620 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $246 |
| Alkermes, Inc. | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Braeburn Inc. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 1 | $112 |
Products named: Auvelity, LYBALVI, FANAPT, BRIXADI, SPRAVATO, COBENFY.
Industry payments across TX — which companies pay providers there.
